ArtificiaI Intelligence in pharma: a legal perspective
Artificial Intelligence (‘AI’) is being used in many sectors and for many reasons. Including pharma. AI technologies (e.g. Machine Learning, Natural Language Processing, Deep Learning) are applied in all stages of drug discovery, for example: target validation, identification of biomarkers, lead optimization, annotation and analysis of clinical data in trails, pharmacovigilance and clinical use optimization. Nonetheless, these AI applications create both regulatory and legal challenges.
In this webinar we will discuss the possibilities of AI in pharma, the present obstacles for the use of AI and possible solutions.
We will also discuss present and future legislation such as the AI Act
In this webinar we will discuss the possibilities of AI in pharma, the present obstacles for the use of AI and possible solutions.
We will also discuss present and future legislation such as the AI Act
